Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apogee Therapeutics Inc | 8,493,321 | 8,493,321 | 0 | $564.38M | $334.21M | 21.28% | -$230.17M |
| Enliven Therapeutics Inc | 4,026,331 | 4,026,331 | 0 | $70.82M | $94.10M | 5.99% | +$23.27M |
| 4d Molecular Therapeutics In | 4,400,000 | 4,400,000 | 0 | $140.18M | $92.36M | 5.88% | -$47.83M |
| Ocular Therapeutix, Inc.(OCUL) | 12,762,462 | 12,762,462 | 0 | $116.14M | $87.30M | 5.56% | -$28.84M |
| Dyne Therapeutics, Inc.(DYN) | 2,173,913 | 2,173,913 | 0 | $61.72M | $76.72M | 4.89% | +$15.00M |
| Merus N V | 1,790,214 | 1,263,214 | -527,000 | $80.61M | $74.74M | 4.76% | -$5.87M |
| Kalvista Pharmaceuticals Inc | 6,249,731 | 6,249,731 | 0 | $74.12M | $73.62M | 4.69% | -$500.0K |
| Pharvaris N V COM | 3,395,606 | 3,395,606 | 0 | $78.47M | $63.84M | 4.07% | -$14.64M |
| Spyre Therapeutics, Inc.(SYRE) | 2,171,782 | 2,685,448 | +513,666 | $82.38M | $63.13M | 4.02% | -$19.24M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,094,373 | 2,094,373 | 0 | $62.83M | $54.20M | 3.45% | -$8.63M |
| Viridian Therapeutics, Inc.(VRDN) | 3,882,671 | 3,882,671 | 0 | $67.99M | $50.51M | 3.22% | -$17.47M |
| Cogent Biosciences, Inc.(COGT) | 5,129,167 | 5,684,167 | +555,000 | $34.47M | $47.92M | 3.05% | +$13.45M |
| Applied Therapeutics Inc | 9,075,000 | 9,542,871 | +467,871 | $61.71M | $44.57M | 2.84% | -$17.14M |
| Erasca, Inc.(ERAS) | 0 | 16,216,216 | +16,216,216 | $0 | $38.27M | 2.44% | +$38.27M |
| Astria Therapeutics Inc | 3,608,645 | 3,608,645 | 0 | $50.79M | $32.84M | 2.09% | -$17.95M |
| Edgewise Therapeutics, Inc.(EWTX) | 1,818,182 | 1,818,182 | 0 | $33.16M | $32.75M | 2.09% | -$418.2K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,394,527 | 4,394,527 | 0 | $60.42M | $31.07M | 1.98% | -$29.36M |
| Praxis Precision Medicines, Inc.(PRAX) | 706,126 | 706,131 | +5 | $43.09M | $29.21M | 1.86% | -$13.88M |
| Engene Holdings Inc COM | 2,565,841 | 2,825,983 | +260,142 | $43.49M | $26.65M | 1.70% | -$16.84M |
| Cullinan Therapeutics, Inc.(CGEM) | 0 | 1,379,965 | +1,379,965 | $0 | $24.07M | 1.53% | +$24.07M |
| Terns Pharmaceuticals Inc | 3,410,058 | 3,410,058 | 0 | $22.37M | $23.22M | 1.48% | +$852.5K |
| Mersana Therapeutics Inc | 11,328,000 | 11,328,000 | 0 | $50.75M | $22.77M | 1.45% | -$27.98M |
| Zura Bio LimitedCL A(ZURA) | 0 | 6,023,166 | +6,023,166 | $0 | $21.08M | 1.34% | +$21.08M |
| Taysha Gene Therapies, Inc.(TSHA) | 9,000,000 | 9,000,000 | 0 | $25.83M | $20.16M | 1.28% | -$5.67M |
| ABIVAX Société AnonymeADS(ABVX) | 1,345,780 | 1,345,780 | 0 | $19.24M | $17.79M | 1.13% | -$1.45M |
| Arvinas, Inc.(ARVN) | 627,788 | 627,788 | 0 | $25.92M | $16.71M | 1.06% | -$9.20M |
| Aquestive Therapeutics Inc | 5,555,555 | 5,555,555 | 0 | $23.67M | $14.44M | 0.92% | -$9.22M |
| Century Therapeutics, Inc.(IPSC) | 3,405,133 | 5,389,259 | +1,984,126 | $14.23M | $13.74M | 0.88% | -$490.8K |
| Cabaletta Bio, Inc.(CABA) | 1,563,952 | 1,563,952 | 0 | $26.68M | $11.70M | 0.75% | -$14.98M |
| Trevi Therapeutics, Inc.(TRVI) | 3,422,675 | 3,422,637 | -38 | $11.81M | $10.20M | 0.65% | -$1.61M |
| Adverum Biotechnologies Inc | 1,556,419 | 1,467,048 | -89,371 | $22.01M | $10.06M | 0.64% | -$11.94M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 0 | 750,000 | +750,000 | $0 | $7.54M | 0.48% | +$7.54M |
| Tenaya Therapeutics, Inc.(TNYA) | 1,555,556 | 1,555,556 | 0 | $8.14M | $4.82M | 0.31% | -$3.31M |
| Arca Biopharma Inc | 0 | 866,375 | +866,375 | $0 | $3.32M | 0.21% | +$3.32M |
| CASI Pharmaceuticals, Inc.(CASIF) | 0 | 111,686 | +111,686 | $0 | $614.3K | 0.04% | +$614.3K |
| Acelyrin Inc | 937,113 | 0 | -937,113 | $6.33M | $0 | — | -$6.33M |
| Celcuity Inc.(CELC) | 970,000 | 0 | -970,000 | $20.95M | $0 | — | -$20.95M |
| CG Oncology, Inc.(CGON) | 350,000 | 0 | -350,000 | $15.37M | $0 | — | -$15.37M |
| EyePoint, Inc.(EYPT) | 250,000 | 0 | -250,000 | $5.17M | $0 | — | -$5.17M |
| Hillevax Inc | 2,075,000 | 0 | -2,075,000 | $34.51M | $0 | — | -$34.51M |
| Immatics N.V.SHS(IMTX) | 1,750,000 | 0 | -1,750,000 | $18.39M | $0 | — | -$18.39M |
| Lyra Therapeutics Inc | 2,576,093 | 0 | -2,576,093 | $16.02M | $0 | — | -$16.02M |
| Mineralys Therapeutics, Inc.(MLYS) | 555,554 | 0 | -555,554 | $7.17M | $0 | — | -$7.17M |
| Olema Pharmaceuticals, Inc.(OLMA) | 77,042 | 0 | -77,042 | $872.1K | $0 | — | -$872.1K |